Equity Research Medical Instruments & Supplies

Should You Buy OraSure Technologies, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, OraSure Technologies, Inc. (OSUR) carries a solid Quality of Company rating of 6.8/10. Trading at $3.46, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 1 of 1 CirclFi valuation models project upside for OraSure Technologies, Inc. (OSUR) at $3.46 — the model consensus leans bullish, with a Quality Score of 6.8/10 and Value-Trap risk of 39/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models see upside — majority bullish
  • Quality Score: 6.8/10 — Moderate — mixed signals
  • Value Trap Risk: 39/100 — Low — manageable risk
  • Fair Value Range: $3.62 – $3.62 (0% spread)

Bullish Models

1 / 1

Bearish Models

0 / 1

Quality Score

6.8 /10

Moderate — mixed signals

Value Trap Risk

39 /100
Low

Low — manageable risk

Model Consensus

1 /13
Active Models

Avg. confidence: 52%

What Is the Investment Case for OraSure Technologies, Inc. (OSUR) in 2026?

What Is the Bull Case vs the Bear Case for OraSure Technologies, Inc. (OSUR)?

Bull case versus bear case for OraSure Technologies, Inc. (OSUR) at $3.46, derived from 1 active CirclFi valuation models on 2026-09-15.
Bull case — $3.62 target (+4.6%) Bear case
No active model projects meaningful upside for OSUR at $3.46. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. No active model flags significant downside for OSUR. The Value Trap score of 39/100 still argues for some caution.

How Does OSUR Compare to Its Medical Instruments & Supplies Peers?

STAA STAAR Surgical Compa
6.8
ANGO AngioDynamics, Inc.
6.7
BLFS BioLife Solutions, I
6.9
AVTR Avantor, Inc.
6.5
NXGL NEXGEL, Inc.
7.0
MMED MiniMed Group, Inc.
6.5
KMTS Kestra Medical Techn
5.8
NNNN Anbio Biotechnology
2.4

Valuation data pages: STAA · ANGO · BLFS · AVTR · NXGL · MMED · KMTS · NNNN · UTMD · ISRG · RMD

See full Medical Instruments & Supplies rankings →

Which Other Stocks Score Like OSUR on Quality?

Closest companies to OSUR’s Quality of Company score of 6.8/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on OSUR?

Spread

0%

Fair Value Range

$3.62 – $3.62

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Dynamic NAV

$3.62 (+4.6%)

Most Bearish

Dynamic NAV

$3.62 (+4.6%)

What Are the Biggest Risks of Buying OSUR Stock?

Macro/Sector Risk

Medical Instruments & Supplies headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View OSUR Data Page →

So Is OraSure Technologies, Inc. (OSUR) Worth Buying in 2026?

Our models don't have a clear verdict on OraSure Technologies, Inc.. At $3.46 vs. $3.62 median fair value, the median upside of +4.6% masks significant model disagreement (+0.0% spread). With quality at 6.8/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.

These are quantitative model outputs, not investment recommendations. OraSure Technologies, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About OSUR Stock?

Should I buy OSUR stock right now?

Based on CirclFi's multi-model analysis, 1 of 1 models see upside for OSUR at $3.46. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.8/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in OraSure Technologies, Inc.?

Key risks include: limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.

How does OSUR compare to its competitors?

Among Medical Instruments & Supplies peers, OSUR holds a Quality Score of 6.8/10. Comparable companies include STAA (QOC 6.8), ANGO (QOC 6.7), BLFS (QOC 6.9). The relative ranking helps investors identify whether OSUR offers better fundamental quality than alternatives in the same sector.

Is OSUR a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. OSUR's Quality Score of 6.8/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy OSUR at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $3.62 to $3.62. At $3.46, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for OSUR.

View OSUR Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →